BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19317815)

  • 1. Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors.
    Levinger I; Goodman C; Peake J; Garnham A; Hare DL; Jerums G; Selig S
    Diabet Med; 2009 Mar; 26(3):220-7. PubMed ID: 19317815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of resistance training on functional capacity and quality of life in individuals with high and low numbers of metabolic risk factors.
    Levinger I; Goodman C; Hare DL; Jerums G; Selig S
    Diabetes Care; 2007 Sep; 30(9):2205-10. PubMed ID: 17563342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort.
    André P; Balkau B; Vol S; Charles MA; Eschwège E;
    Diabetes Care; 2007 Sep; 30(9):2355-61. PubMed ID: 17586745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance training improves depressive symptoms in individuals at high risk for type 2 diabetes.
    Levinger I; Selig S; Goodman C; Jerums G; Stewart A; Hare DL
    J Strength Cond Res; 2011 Aug; 25(8):2328-33. PubMed ID: 21659891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population.
    Lee MY; Koh SB; Koh JH; Nam SM; Shin JY; Shin YG; Kong ID; Ryu SY; Lee TY; Park JK; Chung CH
    Diabet Med; 2008 Apr; 25(4):469-75. PubMed ID: 18346161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome.
    Preiss D; Sattar N; Harborne L; Norman J; Fleming R
    Int J Clin Pract; 2008 Sep; 62(9):1337-43. PubMed ID: 18565127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women.
    Devries MC; Samjoo IA; Hamadeh MJ; Tarnopolsky MA
    Obesity (Silver Spring); 2008 Oct; 16(10):2281-8. PubMed ID: 18719669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF, metabolic risk factors, and resistance training in middle-aged individuals.
    Levinger I; Goodman C; Matthews V; Hare DL; Jerums G; Garnham A; Selig S
    Med Sci Sports Exerc; 2008 Mar; 40(3):535-41. PubMed ID: 18379218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
    St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
    J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome.
    Kerner A; Avizohar O; Sella R; Bartha P; Zinder O; Markiewicz W; Levy Y; Brook GJ; Aronson D
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):193-7. PubMed ID: 15499043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers in relation to insulin resistance and the metabolic syndrome.
    Ingelsson E; Hulthe J; Lind L
    Eur J Clin Invest; 2008 Jul; 38(7):502-9. PubMed ID: 18489581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
    Ryu SY; Kim KS; Park J; Kang MG; Han MA
    J Prev Med Public Health; 2008 Nov; 41(6):413-8. PubMed ID: 19037171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of resistance training on cytokines and osteoprotegerin in women with metabolic syndrome.
    Pereira GB; Tibana RA; Navalta J; Sousa NM; Córdova C; Souza VC; Nóbrega OT; Prestes J; Perez SE
    Clin Physiol Funct Imaging; 2013 Mar; 33(2):122-30. PubMed ID: 23383690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study.
    Schindhelm RK; Dekker JM; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ; Diamant M
    Diabet Med; 2007 Apr; 24(4):430-5. PubMed ID: 17388959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome.
    Kaushik SV; Plaisance EP; Kim T; Huang EY; Mahurin AJ; Grandjean PW; Mathews ST
    Diabetes Metab Res Rev; 2009 Jul; 25(5):427-34. PubMed ID: 19405044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome.
    Yamada J; Tomiyama H; Yambe M; Koji Y; Motobe K; Shiina K; Yamamoto Y; Yamashina A
    Atherosclerosis; 2006 Nov; 189(1):198-205. PubMed ID: 16405892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying the n-6/n-3 polyunsaturated fatty acid ratio of a high-saturated fat challenge does not acutely attenuate postprandial changes in inflammatory markers in men with metabolic syndrome.
    Tulk HM; Robinson LE
    Metabolism; 2009 Dec; 58(12):1709-16. PubMed ID: 19625064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple biomarkers and their relative contributions to identifying metabolic syndrome.
    Lee JG; Lee S; Kim YJ; Jin HK; Cho BM; Kim YJ; Jeong DW; Park HJ; Kim JE
    Clin Chim Acta; 2009 Oct; 408(1-2):50-5. PubMed ID: 19622349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.
    Ebrahimi A; Nabipour I; Vahdat K; Jafari SM; Fouladvand M; Assadi M; Movahed A; Obeidi N; Sanjdideh Z
    Diabetes Res Clin Pract; 2009 Jun; 84(3):296-302. PubMed ID: 19362745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.